Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 1782 Records) |
| Query Trace: Breast Neoplasms and BRCA2[original query] |
|---|
| Universal Genetic Testing for Newly Diagnosed Invasive Breast Cancer. JAMA network open 2024 9 7 (9): e2431427. Zoulikha Rezoug, Stephanie P Totten, David Szlachtycz, Adrienne Atayan, Kristen Mohler, Sophie Albert, Leila Feng, Brianna Lemieux Anglin, Zhen Shen, Daniel Jimenez, Nancy Hamel, Nicholas Meti, Khashayar Esfahani, Jean-François Boileau, Ipshita Prakash, Mark Basik, Sarkis Meterissian, Francine Tremblay, David Fleiszer, Dawn Anderson, George Chong, Stephanie M Wong, William D Foulk |
| The Association Between Breast Cancer Predisposing Genetic Variants and Multifocal, Multicentric Breast Cancer. Annals of surgical oncology 2024 9 . Mahtab Vasigh, Ahmed Mohamed, Lisa Jacobs, Julie Lange, Melissa Camp, Bonnie Sun, Pamela Wright, Maureen O'Donnell, Hanh-Tam Tran, Olutayo Sogunro, Mehran Habibi, Fabian Johnston, David Euh |
| Screening Familial Risk for Hereditary Breast and Ovarian Cancer. JAMA network open 2024 9 7 (9): e2435901. Daniel Kiser, Gai Elhanan, Alexandre Bolze, Iva Neveux, Karen A Schlauch, William J Metcalf, Elizabeth T Cirulli, Catherine McCarthy, Leslie A Greenberg, Savanna Grime, Jamie M Schnell Blitstein, William Plauth, Joseph J Grzyms |
| Prevalence, prognosis, and health care resource utilization in carriers of pathogenic germline variants in BRCA1/2 with incident early-stage breast cancer: a Finnish population-based study. Acta oncologica (Stockholm, Sweden) 2024 9 63 736-745. Peeter Karihtala, Outi Laatikainen, Samuli Tuominen, Trude Ågesen, Rasmus Elias |
| Characteristics and clinical outcomes of breast cancer in young BRCA carriers according to tumor histology. ESMO open 2024 9 9 (10): 103714. E Agostinetto, M Bruzzone, A-S Hamy, H J Kim, C Chiodi, R Bernstein-Molho, S Linn, K Pogoda, E Carrasco, F Derouane, J Bajpai, G Nader-Marta, N Lopetegui-Lia, A H Partridge, L Cortesi, C Rousset-Jablonski, F Giugliano, T Renaud, A Ferrari, S Paluch-Shimon, R Fruscio, W Cui, S M Wong, C Vernieri, K J Ruddy, M V Dieci, A Matikas, M Rozenblit, D Aguilar Y Mendez, L De Marchis, R Borea, F Puglisi, M Pistelli, J Kufel-Grabowska, R Di Rocco, E Mariamidze, F Atzori, H R Kourie, L Popovic, E de Azambuja, E Blondeaux, M Lamberti |
| Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification. medRxiv : the preprint server for health sciences 2024 9 . Maria Zanti, Denise G O'Mahony, Michael T Parsons, Leila Dorling, Joe Dennis, Nicholas J Boddicker, Wenan Chen, Chunling Hu, Marc Naven, Kristia Yiangou, Thomas U Ahearn, Christine B Ambrosone, Irene L Andrulis, Antonis C Antoniou, Paul L Auer, Caroline Baynes, Clara Bodelon, Natalia V Bogdanova, Stig E Bojesen, Manjeet K Bolla, Kristen D Brantley, Nicola J Camp, Archie Campbell, Jose E Castelao, Melissa H Cessna, Jenny Chang-Claude, Fei Chen, Georgia Chenevix-Trench, , Don M Conroy, Kamila Czene, Arcangela De Nicolo, Susan M Domchek, Thilo Dörk, Alison M Dunning, A Heather Eliassen, D Gareth Evans, Peter A Fasching, Jonine D Figueroa, Henrik Flyger, Manuela Gago-Dominguez, Montserrat García-Closas, Gord Glendon, Anna González-Neira, Felix Grassmann, Andreas Hadjisavvas, Christopher A Haiman, Ute Hamann, Steven N Hart, Mikael B A Hartman, Weang-Kee Ho, James M Hodge, Reiner Hoppe, Sacha J Howell, , Anna Jakubowska, Elza K Khusnutdinova, Yon-Dschun Ko, Peter Kraft, Vessela N Kristensen, James V Lacey, Jingmei Li, Geok Hoon Lim, Sara Lindström, Artitaya Lophatananon, Craig Luccarini, Arto Mannermaa, Maria Elena Martinez, Dimitrios Mavroudis, Roger L Milne, Kenneth Muir, Katherine L Nathanson, Rocio Nuñez-Torres, Nadia Obi, Janet E Olson, Julie R Palmer, Mihalis I Panayiotidis, Alpa V Patel, Paul D P Pharoah, Eric C Polley, Muhammad U Rashid, Kathryn J Ruddy, Emmanouil Saloustros, Elinor J Sawyer, Marjanka K Schmidt, Melissa C Southey, Veronique Kiak-Mien Tan, Soo Hwang Teo, Lauren R Teras, Diana Torres, Amy Trentham-Dietz, Thérèse Truong, Celine M Vachon, Qin Wang, Jeffrey N Weitzel, Siddhartha Yadav, Song Yao, Gary R Zirpoli, Melissa S Cline, Peter Devilee, Sean V Tavtigian, David E Goldgar, Fergus J Couch, Douglas F Easton, Amanda B Spurdle, Kyriaki Michailid |
| Phenotypes of carriers of two mutated alleles in major cancer susceptibility genes. Breast cancer research and treatment 2024 8 . Yael Laitman, Anni Niskakoski, Rinal Bernstein-Molho, Lotta Koskinen, Daniel Rabina, Juha Koskenvuo, Eitan Friedm |
| BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance. Molecular cancer 2024 8 23 (1): 158. Ksenija Nesic, John J Krais, Yifan Wang, Cassandra J Vandenberg, Pooja Patel, Kathy Q Cai, Tanya Kwan, Elizabeth Lieschke, Gwo-Yaw Ho, Holly E Barker, Justin Bedo, Silvia Casadei, Andrew Farrell, Marc Radke, Kristy Shield-Artin, Jocelyn S Penington, Franziska Geissler, Elizabeth Kyran, Robert Betsch, Lijun Xu, Fan Zhang, Alexander Dobrovic, Inger Olesen, Rebecca Kristeleit, Amit Oza, Iain McNeish, Gayanie Ratnayake, Nadia Traficante, , Anna DeFazio, David D L Bowtell, Thomas C Harding, Kevin Lin, Elizabeth M Swisher, Olga Kondrashova, Clare L Scott, Neil Johnson, Matthew J Wakefie |
| The Clinical and Genetic Landscape of Hereditary Cancer: Experience from a Single Clinical Diagnostic Laboratory. Cancer genomics & proteomics 2024 8 21 (5): 448-463. Nikolaos Tsoulos, Konstantinos Agiannitopoulos, Kevisa Potska, Anastasia Katseli, Christina Ntogka, Georgia Pepe, Dimitra Bouzarelou, Athanasios Papathanasiou, Dimitrios Grigoriadis, Georgios N Tsaousis, Helen Gogas, Theodore Troupis, Konstantinos Papazisis, Ioannis Natsiopoulos, Vassileios Venizelos, Kyriakos Amarantidis, Stylianos Giassas, Christos Papadimitriou, Elena Fountzilas, Maroulio Stathoulopoulou, Anna Koumarianou, Grigorios Xepapadakis, Alexandru Blidaru, Daniela Zob, Oana Voinea, Mustafa Özdo?an, Mahmut Çerkez Ergören, Alinta Hegmane, Eirini Papadopoulou, George Nasioulas, Christos Markopoul |
| The Pathological Pattern of Breast Cancer in the Najran Region of Saudi Arabia: A Retrospective Study. Cureus 2024 8 16 (8): e67621. Abdulrahman M Alamri, Hajar H AlWadai, Saad M Almowallad, Saleh M AlKulayb, Zahra E Abdalwahab, Shuruq M Alzahuf, Saleh H Alshaib |
| BRCA1/2 mutations and outcomes among Middle Eastern patients with early-onset breast cancer in Oman. The oncologist 2024 8 . Waleed S Al Amri, Ahmed H Al Amri, Aisha Al Abri, Thomas A Hughes, Fatma Al Lawa |
| Hypermethylation of the BRCA2 gene promoter and its co-hypermethylation with the BRCA1 gene promoter in patients with breast cancer. Cancer biomarkers : section A of Disease markers 2024 8 . Liliia Fishchuk, Zoia Rossokha, Olga Lobanova, Valeriy Cheshuk, Roman Vereshchako, Viktoriia Vershyhora, Nataliia Medvedieva, Olha Dubitskaa, Natalia Goroven |
| General analysis of breast cancer patients tested for BRCA mutations and evaluation of acute radiotherapy toxicity. Northern clinics of Istanbul 2024 8 11 (4): 302-308. Sule Karabulut Gul, Huseyin Tepetam, Berrin Benli Yavuz, Ozge Kandemir Gursel, Ayse Altinok, Irem Yuksel, Omar Alomari, Banu Atalar, Ilknur Bilkay Gork |
| Clinical significance of germline breast cancer susceptibility gene (gBRCA) testing and olaparib as maintenance therapy for patients with pancreatic cancer. BMC cancer 2024 8 24 (1): 1000. Yasuharu Kawamoto, Takuo Yamai, Kenji Ikezawa, Yusuke Seiki, Ko Watsuji, Takeru Hirao, Makiko Urabe, Yugo Kai, Ryoji Takada, Kaori Mukai, Tasuku Nakabori, Hiroyuki Uehara, Tazuko Inoue, Fumie Fujisawa, Kazuyoshi Ohka |
| In Silico Prediction of BRCA1 and BRCA2 Variants with Conflicting Clinical Interpretation in a Cohort of Breast Cancer Patients. Genes 2024 7 15 (7): . Stefania Stella, Silvia Rita Vitale, Michele Massimino, Federica Martorana, Irene Tornabene, Cristina Tomarchio, Melissa Drago, Giuliana Pavone, Cristina Gorgone, Chiara Barone, Sebastiano Bianca, Livia Manzel |
| Double Heterozygosity for Germline Mutations in Chinese Breast Cancer Patients. Cancers 2024 7 16 (14): . Ava Kwong, Cecilia Y S Ho, Chun-Hang Au, Edmond S K |
| Pathologic complete response after neoadjuvant systemic therapy for breast cancer in BRCA mutation carriers and noncarriers. NPJ breast cancer 2024 7 10 (1): 63. Sara P Myers, Varadan Sevilimedu, Andrea V Barrio, Audree B Tadros, Anita Mamtani, Mark E Robson, Monica Morrow, Minna K L |
| Genomic profiling and comparative analysis of male versus female metastatic breast cancer across subtypes. Breast cancer research : BCR 2024 7 26 (1): 118. Arun Kadamkulam Syriac, Nitish Singh Nandu, Allison Clark, Mehrad Tavallai, Dexter X Jin, Ethan Sokol, Kimberly McGregor, Jeffrey S Ross, Natalie Danziger, Jose Pablo Leo |
| Somatic and germline aberrations in homologous recombination repair genes among Chinese high-risk breast cancer patients by multi-gene next-generation sequencing. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2024 7 . Ling Xie, Jie Chen, YanYing Zheng, Yi Sun, Xiang Zhang, LeLe Chu, YiFen Zha |
| The pathologic and clinical outcomes of risk-reducing salpingo-oophorectomy in asymptomatic carriers of homologous recombination repair gene mutation. Journal of gynecologic oncology 2024 7 . Yeon Jee Lee, Ji Hyun Kim, Youn Jee Kim, Yoon Jung Chang, Sun-Young Kong, Chong Woo Yoo, Dong Ock Lee, Sang-Soo Seo, Sokbom Kang, Sang-Yoon Park, Myong Cheol L |
| [Examination of breast density in breast cancer discordant twin pairs]. Magyar onkologia 2024 7 68 (2): 171-176. Szilárd Veres, Fruzsina Martinovszky, Márk Di Giovanni, Bettina Budai, Beatrix Beszedics, István Szabó, Henriett Butz, Attila Patócs, Bálint Török, Mátyás Ujlaki, László Dávid Tárnoki, Domonkos Ádám Tárno |
| Genomic Alterations Correlated to Trastuzumab Resistance and Clinical Outcomes in HER2+/HR- Breast Cancers of Patients Living in Northwestern China. Journal of Cancer 2024 7 15 (14): 4467-4476. Gang Ma, Binliang Huo, Yanwei Shen, Xulong Zhu, Chong Cheng, Wensheng Li, Wei Cao, Jianhui |
| Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer. NPJ breast cancer 2024 7 10 (1): 57. Peter A Fasching, Chunling Hu, Steven N Hart, Matthias Ruebner, Eric C Polley, Rohan D Gnanaolivu, Andreas D Hartkopf, Hanna Huebner, Wolfgang Janni, Peyman Hadji, Hans Tesch, Sabrina Uhrig, Johannes Ettl, Michael P Lux, Diana Lüftner, Markus Wallwiener, Lena A Wurmthaler, Chloë Goossens, Volkmar Müller, Matthias W Beckmann, Alexander Hein, Daniel Anetsberger, Erik Belleville, Pauline Wimberger, Michael Untch, Arif B Ekici, Hans-Christian Kolberg, Arndt Hartmann, Florin-Andrei Taran, Tanja N Fehm, Diethelm Wallwiener, Sara Y Brucker, Andreas Schneeweiss, Lothar Häberle, Fergus J Cou |
| Population-based germline breast cancer gene association studies and meta-analysis to inform wider mainstream testing. Annals of oncology : official journal of the European Society for Medical Oncology 2024 7 . C F Rowlands, S Allen, J Balmaña, S M Domchek, D G Evans, H Hanson, N Hoogerbrugge, P A James, K Nathanson, M Robson, M Tischkowitz, W D Foulkes, C Turnbu |
| Digenic Inheritance of Mutations in Homologous Recombination Genes in Cancer Patients. Journal of personalized medicine 2024 6 14 (6): . Maria Valeria Freire, Marie Martin, Karin Segers, Edith Sepulchre, Natacha Leroi, Jérôme Coupier, Hassan Rezaei Kalantari, Pascal Wolter, Joëlle Collignon, Marc Polus, Olivier Plomteux, Claire Josse, Vincent Bou |
| BRCA1, BRCA2 and PALB2 mRNA Expression as Prognostic Markers in Patients with Early Breast Cancer. Biomedicines 2024 6 12 (6): . Ina Shehaj, Slavomir Krajnak, Katrin Almstedt, Yaman Degirmenci, Sophia Herzog, Antje Lebrecht, Valerie Catherine Linz, Roxana Schwab, Kathrin Stewen, Walburgis Brenner, Annette Hasenburg, Marcus Schmidt, Anne-Sophie Heim |
| BRCA2 mutations in familial breast cancer with prostate cancer: a case report and literature review. Frontiers in oncology 2024 10 14 1428849. Zhengsheng Liu, Qianhao Huang, Meixuan Ding, Tao Wang, Yuedong Chen, Kaiyan Zha |
| Development of a novel prediction model for carriage of BRCA1/2 pathogenic variant in Japanese patients with breast cancer based on Japanese organization of hereditary breast and ovarian cancer registry data. Breast cancer research and treatment 2024 10 . Nana Komatsu, Takashi Chishima, Chie Watanabe, Kanae Taruno, Mayuko Inuzuka, Masanori Oshi, Masami Arai, Seigo Nakamu |
| Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in BRCA1 and BRCA2. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2024 10 JCO2400176. Kelly-Anne Phillips, Joanne Kotsopoulos, Susan M Domchek, Mary Beth Terry, James A Chamberlain, Julie K Bassett, Amber M Aeilts, Irene L Andrulis, Saundra S Buys, Wanda Cui, Mary B Daly, Andrea F Eisen, William D Foulkes, Michael L Friedlander, Jacek Gronwald, John L Hopper, Esther M John, Beth Y Karlan, Raymond H Kim, Allison W Kurian, Jan Lubinski, Kelly Metcalfe, Katherine L Nathanson, Christian F Singer, Melissa C Southey, Heather Symecko, Nadine Tung, Steven A Narod, Roger L Milne, , |
| Homologous recombination deficiency gene panel analysis results in synchronous endometrial and ovarian cancers. Revista da Associacao Medica Brasileira (1992) 2024 10 70 (10): e20240534. Ferah Kazanci, Zerrin Y?lmaz Çelik, Mert Polat, Ferhat Karademir, Ozlem Erdem, Feride ?ffet ?ahin, Mehmet Anil On |
- Page last reviewed:Feb 1, 2024
- Content source: